Comparison

Deapioplatycodin D European Partner

Item no. TMO-T3821-10mg
Manufacturer TargetMol
CASRN 78763-58-3
Amount 10 mg
Quantity options 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 99.64%
Citations Jeong EK., et al. Glycosylated platycosides: identification by enzymatic hydrolysis and structural determination by LC-MS/MS. J Sep Sci. 2014 Jan;37(1-2):61-8.
Smiles [H][C@@]1(O[C@H]2[C@H](C)O[C@@]([H])(O[C@@H]3[C@@H](O)[C@@H](O)CO[C@H]3OC(=O)[C@]34CCC(C)(C)C[C@@]3([H])C3=CC[C@]5([H])[C@@]6(C)C[C@H](O)[C@H](O[C@]7([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)C(CO)(CO)[C@]6([H])CC[C@@]5(C)[C@]3(C)C[C@H]4O)[C@H](O)[C@@H]2O)OC[C@@H](O)[C@H](O)[C@H]1O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Deapi-platycodin D,DesapioplatycodinD
Shipping Condition Cool pack
Available
Manufacturer - Targets
HCV Protease
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
1093.21
Description
Deapioplatycodin D and platycodin D can regulate the production and secretion of airway mucin and, at least in part, explains the traditional use of aqueous extract of APG as expectorants in diverse inflammatory pulmonary diseases. Deapi-platycodin D has anti-inflammatory activity.
Pathways
Proteases/Proteasome|||Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close